Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Gets FDA Clearance for CE Sequencing Systems, HLA Assay

NEW YORK (GenomeWeb News) – Life Technologies said today that it has received US Food and Drug Administration 510(k) clearance for capillary electrophoresis sequencing systems and an HLA typing assay.

The company's 3500 Dx Genetic Analyzers and its SeCore HLA typing kits are the first 510(k)-cleared, sequencing-based systems for HLA typing in the US, the firm noted.

"Sanger sequencing remains the gold standard for providing the reliable results clinical labs need, and 510(k) clearance of the 3500Dx will help to establish sequencing technology as a mainstay of the hospital lab," Ronnie Andrews, Life Tech's president of medical sciences, said in a statement. "The instrument was designed with the clinical laboratory in mind, featuring a novel design that incorporates the ability to track reagent usage with radio frequency identification (RFID) tags, as well as redesigned data collection and analysis software."

As reported by GenomeWeb Daily News sister publication Clinical Sequencing News, the company submitted its machine and assay for clearance two years ago. The HLA test covers six genes within the major histocompatibilty complex, including the Class I genes HLA-A, HLA-B, and HLA-C, as well as the Class II genes DRB1, DQB1, and DPB1.

Included in the current 510(k) clearance are the 3500 Dx/3500xL Dx Genetic Analyzers CS2; 3500 Dx Series data collection software v1.0; SeCore HLA sequencing kits; and uTYPE Dx HLA sequence analysis software.

The 3500 Dx machine is also CE-marked for in vitro diagnostic use in Europe and has been approved by China's State Food and Drug Administration for diagnostic use.

Life Tech also plans to submit its Ion Torrent PGM next-generation sequencing machine for 510(k) clearance this year.

"We will continue to aggressively pursue a regulatory pathway for our leading technologies in the clinical space, including next-generation sequencing," Life Tech Chairman and CEO Greg Lucier said in the statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.